ロード中...
Light activated, In situ Forming Gel for Sustained Suprachoroidal Delivery of Bevacizumab
PURPOSE: To develop a light activated polycaprolactone dimethacrylate and hydroxyethyl methacrylate based gel network that sustains the release of stable, active bevacizumab (an anti-VEGF antibody used to treat choroidal neovascularization) and to assess sustained ex vivo delivery in rabbit eyes and...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4003910/ https://ncbi.nlm.nih.gov/pubmed/23734705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp300716t |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|